|
|
||||||||||
|
J Am Coll Cardiol, 1997; 30:334-342 © 1997 by the American College of Cardiology Foundation |
Department of Internal Medicine, University of Michigan, Ann Arbor, USA.
Although thrombolytic therapy for acute myocardial infarction (MI) is recommended without regard for infarct location, treatment results are less impressive for inferior than for anterior MI because the amount of myocardium at risk is smaller and less strategically located, and the mortality risk is lower. Whereas the risks associated with anterior MI are relatively constant, high risk subsets of patients with an inferior MI can be identified by simple electrocardiographic criteria, including left precordial ST segment depression, complete atrioventricular heart block and right precordial ST segment elevation. Unfortunately, none of the placebo-controlled, randomized trials have analyzed the benefit of thrombolytic therapy for inferior MI in high risk versus low risk subsets. Thrombolytic therapy should be more successful in reducing infarct size and decreasing mortality in high risk patients with an inferior MI. Thrombolytic therapy may not decrease hospital mortality in low risk patients (baseline risk 2% to 4%) or those with symptom duration > 6 h. Whereas it is arguable whether coronary angioplasty is superior to thrombolytic therapy in anterior MI, there are no mortality data to support using angioplasty as a primary or rescue reperfusion strategy instead of thrombolytic therapy in inferior MI, unless thrombolytic contraindications are present or the patient is in cardiogenic shock.
This article has been cited by other articles:
![]() |
E. R. Bates and B. K. Nallamothu Commentary: The Role of Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction Circulation, July 29, 2008; 118(5): 567 - 573. [Full Text] [PDF] |
||||
![]() |
American College of Cardiology/American Heart Asso, Developed in Collaboration With the Canadian Cardi, Endorsed by the American Academy of Family Physici, 2007 Writing Group to Review New Evidence and Upda, E. M. Antman, M. Hand, P. W. Armstrong, E. R. Bates, L. A. Green, L. K. Halasyamani, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction J. Am. Coll. Cardiol., January 15, 2008; 51(2): 210 - 247. [Full Text] [PDF] |
||||
![]() |
American College of Cardiology/American Heart Asso, 2007 Writing Group to Review New Evidence and Upda, S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, and D. O. Williams 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention J. Am. Coll. Cardiol., January 15, 2008; 51(2): 172 - 209. [Full Text] [PDF] |
||||
![]() |
E. M. Antman, M. Hand, P. W. Armstrong, E. R. Bates, L. A. Green, L. K. Halasyamani, J. S. Hochman, H. M. Krumholz, G. A. Lamas, C. J. Mullany, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee Circulation, January 15, 2008; 117(2): 296 - 329. [Full Text] [PDF] |
||||
![]() |
S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, D. O. Williams, 2005 WRITING COMMITTEE MEMBERS, S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee Circulation, January 15, 2008; 117(2): 261 - 295. [Full Text] [PDF] |
||||
![]() |
M. C. Tjandrawidjaja, Y. Fu, H. Al-Khalidi, T. G. Todaro, P. Adams, F. Van de Werf, C. B. Granger, P. W. Armstrong, and on behalf of the APEX-AMI Investigators Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI Eur. Heart J., December 1, 2007; 28(23): 2850 - 2857. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Selker, J. R. Beshansky, J. L. Griffith, and for the TPI Trial Investigators* Use of the Electrocardiograph-Based Thrombolytic Predictive Instrument To Assist Thrombolytic and Reperfusion Therapy for Acute Myocardial Infarction: A Multicenter, Randomized, Controlled, Clinical Effectiveness Trial Ann Intern Med, July 16, 2002; 137(2): 87 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Sasao, K Tsuchihashi, M Hase, T Nakata, K Shimamoto, and t. N.-9. investigators Does primary stenting preserve cardiac function in myocardial infarction? A case-control study Heart, November 1, 2000; 84(5): 515 - 521. [Abstract] [Full Text] |
||||
![]() |
G. C. Friesinger II and R. F. Smith Old age, left bundle branch block and acute myocardial infarction: a vexing and lethal combination J. Am. Coll. Cardiol., September 1, 2000; 36(3): 713 - 716. [Full Text] [PDF] |
||||
![]() |
F. Ribichini, G. Steffenino, A. Dellavalle, V. Ferrero, A. Vado, M. Feola, and E. Uslenghi Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: Immediate and long-term results of a randomized study J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1687 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bueno, R. Lopez-Palop, E. Perez-David, J. Garcia-Garcia, J. L. Lopez-Sendon, and J. L. Delcan Combined Effect of Age and Right Ventricular Involvement on Acute Inferior Myocardial Infarction Prognosis Circulation, October 27, 1998; 98(17): 1714 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Zeymer, K.-L. Neuhaus, K. Wegscheider, U. Tebbe, P. Molhoek, R. Schroder, and for the HIT-4 Trial Group Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement J. Am. Coll. Cardiol., October 1, 1998; 32(4): 876 - 881. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |